# Twist Bioscience Announces Fiscal 2026 First Quarter Financial Results
Canonical URL: https://biopharmsignal.com/news/TWST/twist-bioscience-announces-fiscal-2026-first-quarter-financial-results
Ticker: TWST
Company: Twist Bioscience Corporation
Source: Twist Bioscience Corporation
Published: 2026-02-02 12:15 EST
Original Source URL: https://investors.twistbioscience.com
## Summary

SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Feb. 2, 2026-- Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced financial results and business highlights for the first quarter fiscal 2026 ended December 31, 2025.

## Article Body
SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Feb. 2, 2026-- Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced financial results and business highlights for the first quarter fiscal 2026 ended December 31, 2025.
## Recent Company News
- 2026-05-27 12:00 EST — [Twist Bioscience to Present at William Blair 46th Annual Growth Stock Conference](https://biopharmsignal.com/news/TWST/twist-bioscience-to-present-at-william-blair-46th-annual-growth-stock-conference) — Source: Twist Bioscience Corporation
- 2026-05-05 12:00 EST — [Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/TWST/twist-bioscience-corporation-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4) — Source: Twist Bioscience Corporation
- 2026-05-04 11:20 EST — [Twist Bioscience Expands Clonal Genes Offering to Include Long and Complex Sequences](https://biopharmsignal.com/news/TWST/twist-bioscience-expands-clonal-genes-offering-to-include-long-and-complex-sequences) — Source: Twist Bioscience Corporation
- 2026-05-04 11:15 EST — [Twist Bioscience Announces Fiscal 2026 Second Quarter Financial Results](https://biopharmsignal.com/news/TWST/twist-bioscience-announces-fiscal-2026-second-quarter-financial-results) — Source: Twist Bioscience Corporation
- 2026-04-21 12:00 EST — [Twist Bioscience to Report Fiscal 2026 Second Quarter Financial Results on Monday, May 4, 2026](https://biopharmsignal.com/news/TWST/twist-bioscience-to-report-fiscal-2026-second-quarter-financial-results-on-monday-may-4-2026) — Source: Twist Bioscience Corporation
## Related News
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)
- 2026-07-29 12:25 EST — ICCM — [IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance  of ProSense®](https://biopharmsignal.com/news/ICCM/icecure-sio-petitions-nccn-to-include-cryoablation-in-breast-cancer-treatment-gu-bec46cd3)